Intra-Cellular Therapies, Inc. Made Headway

Intra-Cellular Therapies, Inc. (ITCI:NASDAQ) shot up at $127.19, a gain of 34.1%. On Mon, Jan 13, 2025, ITCI:NASDAQ touched a New 2-Week High of $127.19. The stock got featured on our News Catalysts scanner on Mon, Jan 13, 2025 at 03:42 PM in the 'PATENT' category. From Mon, Dec 30, 2024, the stock recorded 62.50% Up Days and 33.33% Green Days
About Intra-Cellular Therapies, Inc. (ITCI:NASDAQ)
Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.
Top 10 Gainers:
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 290.53%
- Smart for Life Inc. (SMFL:NASDAQ), 260%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 135.26%
- Kairos Pharma Ltd. (KAPA:NYSEMKT), 119.59%
- Azitra Inc (AZTR:NYSEMKT), 59.72%
- Agape ATP Corporation (ATPC:NASDAQ), 56.35%
- Avinger, Inc. (AVGR:NASDAQ), 42.62%
- Neuronetics, Inc. (STIM:NASDAQ), 36.84%
- Sage Therapeutics, Inc. (SAGE:NASDAQ), 35.14%
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 34.07%